RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION
The present report reviews various aspects of legal regulation, function, guidelines for creation and sources of finance pertaining to the restrictive lists of drugs, which play a substantial role in the drug supply policy in theRussian Federation. The following restrictive lists (currently in effec...
Sábháilte in:
Príomhchruthaitheoir: | |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
IRBIS LLC,
2017-05-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_dd0f2ad857da47e5bfcd11f2f26d3cb0 | ||
042 | |a dc | ||
100 | 1 | 0 | |a M. V. Sura |e author |
245 | 0 | 0 | |a RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION |
260 | |b IRBIS LLC, |c 2017-05-01T00:00:00Z. | ||
500 | |a 2070-4909 | ||
500 | |a 2070-4933 | ||
500 | |a 10.17749/2070-4909.2017.10.1.046-056 | ||
520 | |a The present report reviews various aspects of legal regulation, function, guidelines for creation and sources of finance pertaining to the restrictive lists of drugs, which play a substantial role in the drug supply policy in theRussian Federation. The following restrictive lists (currently in effect) are carefully analyzed: the list of VED, the list of medications supplied to certain population groups, the list of "7 medical conditions", the minimum assortment, the lists of regional benefits, the lists of medicines to treat rare diseases, in accordance with the list of rare (orphan) diseases, the list of strategically important medications, the list of drugs allowed for tax deduction. | ||
546 | |a RU | ||
690 | |a restrictive lists of drugs | ||
690 | |a legal regulation of drug supply | ||
690 | |a financing of drug supply | ||
690 | |a state guarantees for free public medical care | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Economics as a science | ||
690 | |a HB71-74 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Фармакоэкономика, Vol 10, Iss 1, Pp 46-56 (2017) | |
787 | 0 | |n https://www.pharmacoeconomics.ru/jour/article/view/182 | |
787 | 0 | |n https://doaj.org/toc/2070-4909 | |
787 | 0 | |n https://doaj.org/toc/2070-4933 | |
856 | 4 | 1 | |u https://doaj.org/article/dd0f2ad857da47e5bfcd11f2f26d3cb0 |z Connect to this object online. |